[go: up one dir, main page]

DK1478438T3 - Fremgangsmåder og sammensætninger til behandling af astma - Google Patents

Fremgangsmåder og sammensætninger til behandling af astma

Info

Publication number
DK1478438T3
DK1478438T3 DK03700218.5T DK03700218T DK1478438T3 DK 1478438 T3 DK1478438 T3 DK 1478438T3 DK 03700218 T DK03700218 T DK 03700218T DK 1478438 T3 DK1478438 T3 DK 1478438T3
Authority
DK
Denmark
Prior art keywords
asthma
compositions
treatment
methods
Prior art date
Application number
DK03700218.5T
Other languages
English (en)
Inventor
Thomas Julius Borody
Original Assignee
Atopic Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Atopic Pty Ltd filed Critical Atopic Pty Ltd
Application granted granted Critical
Publication of DK1478438T3 publication Critical patent/DK1478438T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/429Thiazoles condensed with heterocyclic ring systems
    • A61K31/43Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41961,2,4-Triazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Emergency Medicine (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK03700218.5T 2002-01-25 2003-01-24 Fremgangsmåder og sammensætninger til behandling af astma DK1478438T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPS0177A AUPS017702A0 (en) 2002-01-25 2002-01-25 Methods and compositions for the treatment of asthma and related disorders
PCT/AU2003/000074 WO2003061767A1 (en) 2002-01-25 2003-01-24 Methods and compositions for the treatment of asthma and related disorders

Publications (1)

Publication Number Publication Date
DK1478438T3 true DK1478438T3 (da) 2012-08-27

Family

ID=3833782

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03700218.5T DK1478438T3 (da) 2002-01-25 2003-01-24 Fremgangsmåder og sammensætninger til behandling af astma

Country Status (7)

Country Link
US (2) US7241741B2 (da)
EP (1) EP1478438B1 (da)
AU (2) AUPS017702A0 (da)
DK (1) DK1478438T3 (da)
ES (1) ES2389539T3 (da)
NZ (1) NZ534845A (da)
WO (1) WO2003061767A1 (da)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6503953B2 (en) * 2000-07-26 2003-01-07 Atopic Pty Ltd. Methods for treating atopic disorders
AUPS088702A0 (en) 2002-03-04 2002-03-28 Borody, Thomas Julius Electrolyte purgative
EP1519719A1 (en) * 2002-07-02 2005-04-06 Novartis AG Methods for the treatment of sinusitis
AU2003261444A1 (en) * 2002-08-09 2004-02-25 Martin H. Bluth A method for monitoring the effectiveness of tetracycline in the treatment of asthma
DE10239531A1 (de) * 2002-08-23 2004-03-04 Gulbins, Erich, Prof. Dr. Prophylaxe und Therapie von Infektionserkrankungen
WO2004064728A2 (en) * 2003-01-16 2004-08-05 Paratek Pharmaceuticals, Inc. Use of specific tetracycline compounds in therapy
WO2005009427A1 (ja) * 2003-07-29 2005-02-03 Cell Signals Inc. アレルギー疾患の治療薬
DE10350409A1 (de) * 2003-10-28 2005-05-25 Bayer Healthcare Ag Behandlung genetisch bedingter Krankheiten
EP2117586B1 (en) 2007-03-15 2018-08-08 Hunter Immunology Pty Ltd Treatment or prophylaxis of asthma
CN102065897B (zh) * 2008-04-29 2013-11-13 法奈科斯公司 基于磺胺异噁唑的组合物用于制备治疗阿茨海默病的药物的应用
LT2282778T (lt) * 2008-04-29 2017-06-26 Pharnext Nauji terapijos būdai, gydant alzheimerio ligą ir susijusius sutrikimus per angiogenezės moduliaciją
BR112012023877A2 (pt) * 2010-03-15 2016-08-02 Univ Virginia Commonwealth dapsona aerossolizada como uma terapia para a inflamação das vias aéreas e transporte mucociliar anormal
WO2012079118A1 (en) 2010-12-13 2012-06-21 Borody Thomas J Gastric and colonic formulations and methods for making and using them
AU2013294737B2 (en) 2012-07-27 2018-05-24 Redhill Biopharma Ltd. Formulations and methods of manufacturing formulations for use in colonic evacuation
US20160068527A1 (en) * 2013-04-09 2016-03-10 Cresset Biomolecular Discovery Ltd. The Treatment of Inflammatory Disorders
CN106974914B (zh) * 2017-04-28 2019-06-21 山东省千佛山医院 利奈唑胺联合氟康唑的抗真菌产品及其应用
CN111491639A (zh) * 2017-09-20 2020-08-04 异位性医疗有限责任公司 用于治疗和改善呼吸道病况和粘膜炎症的组合物和方法
CA3126367A1 (en) * 2020-03-30 2021-09-30 Pulmonem Inc. Dapsone formulations and methods of using same
WO2022094079A1 (en) * 2020-10-28 2022-05-05 The Trustees Of Dartmouth College Methods of treating cystic fibrosis

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL340606A1 (en) * 1997-10-22 2001-02-12 Jens Ponikau Methods of and materials for treating and preventing mucositis
AUPP437698A0 (en) * 1998-06-30 1998-07-23 Baumgart, Karl Methods for treatment of coronary, carotid and other vascular disease
US20010038825A1 (en) * 2000-02-04 2001-11-08 Hite Robert Duncan Method and compositions for enhancing pulmonary function and treating pulmonary disorders
US6503953B2 (en) * 2000-07-26 2003-01-07 Atopic Pty Ltd. Methods for treating atopic disorders

Also Published As

Publication number Publication date
AU2003201523B2 (en) 2007-03-01
NZ534845A (en) 2006-04-28
US20050054588A1 (en) 2005-03-10
WO2003061767A1 (en) 2003-07-31
US7776850B2 (en) 2010-08-17
ES2389539T3 (es) 2012-10-29
EP1478438A1 (en) 2004-11-24
EP1478438A4 (en) 2007-11-14
US7241741B2 (en) 2007-07-10
AUPS017702A0 (en) 2002-02-14
EP1478438B1 (en) 2012-06-13
US20080076726A1 (en) 2008-03-27

Similar Documents

Publication Publication Date Title
DK1420759T3 (da) Farmaceutiske sammensætninger til behandling af astma
DK1644021T3 (da) Fremgangsmåder og sammensætninger til behandlingen af gastrointestinale sygdomme
DK1478438T3 (da) Fremgangsmåder og sammensætninger til behandling af astma
DK1583542T3 (da) Sammensætninger og fremgangsmåder til antiviral kombinationsterapi
DK1667986T3 (da) Acetonesolvat af dimethoxydocetaxel og fremgangsmåde til fremstilling heraf
DK1830838T3 (da) Sammensætninger og fremgangsmåder til behandling af neoplastiske sygdomme
DK2308507T3 (da) Fremgangsmåder til behandling af præeklampsi
NO20032220D0 (no) Löfteverktöy II og fremgangsmåte for anvendelse av samme
DK1638999T3 (da) Sammensætninger og fremgangsmåder til øgning af knoglemineralisering
DK1824475T3 (da) Fremgangsmåde til oprensning af trans-(-)-delta9-tetrahydrocannabinol og trans-(+)-delta9-tetrahydrocannabinol
NO20044148L (no) Sammensetning og fremgangsmate for bronnrensing
IS8451A (is) Aðferðir og hvarfefni til að meðhöndla ónæmisbólgusjúkdóma
IS8410A (is) Aðferðir og hvarfefni til að meðhöndla ónæmisbólgusjúkdóma
DK1663978T3 (da) Fluorsubstitueret omega-carboxyaryl-diphenylurinstof til behandling og forebyggelse af sygdomme og lidelser
NO20053114D0 (no) Astma og allergisk inflammasjonsmodulatorer.
DK1888033T3 (da) Fremgangsmåde og sammensætning til behandling af inflammatoriske sygdomme
DK2508521T4 (da) Dimaleat af en aminocrotonylforbindelse og fremgangsmåde til fremstilling deraf
IS7684A (is) Ný efnasambönd, blöndur og aðferðir til að meðhöndla bólgusjúkdóma og -ástand
DK1506041T3 (da) Inbandronsyre til behandling og forebyggelse af osteoporose
DK1667730T3 (da) Sammensætninger og fremgangsmåder til behandling af inflammatorisk lungesygdom
NO20021786D0 (no) Skumdempningsfremgangsmåter og sammensetninger
NO20033854L (no) N-but-3-enyl-norbuprenorfin og fremgangsmåter for anvendelse
DK1601744T3 (da) Forgasningsapparat og fremgangsmåde
DK1599469T3 (da) Tetrazolderivater og fremgangsmåder til behandling af metabolismerelaterede forstyrrelser dermed
DK1589973T4 (da) Formulering og fremgangsmåder til behandling af thrombocytæmi